Bluejay DiagnosticsBJDX
13F holders, Q3 2025 (September 30)4holders −1
1new positions
2sold out
$1.52avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Bluejay Diagnostics Inc. (BJDX) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 2 sold out. The largest holders were DRW Securities, LLC ($91K), Sabby Management, LLC ($45K) and Tower Research Capital LLC (TRC) ($7K).
- Company
- Bluejay Diagnostics Inc.
- CUSIP
- 095633509
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $91K |
| Exits | 2 | $1K |
All 13F filers, Q2 2025 → Q3 2025: 61,950 shares bought and 67,090 shares sold, net −5,140 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| DRW Securities, LLC | 0.00% | New | 59,767 | $91K |
| Sabby Management, LLC | 0.24% | Reduce -69.2% | 29,628 | $45K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +95.8% | 4,448 | $7K |
| Bank of America Corp. | 0.00% | Add +140.0% | 12 | $18 |
"% of holder's portfolio" is BJDX's weight in each manager's 13F, not the share of Bluejay Diagnostics Inc. the manager owns.